Old Web
English
Sign In
Acemap
>
authorDetail
>
Satya Siddani
Satya Siddani
AbbVie
Venetoclax
Medicine
Population
Ven
Refractory
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Venetoclax in Combination with Gilteritinib Demonstrates Molecular Clearance of FLT3 mutation in Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia
2021
Blood
Naval Daver
Alexander E. Perl
Joseph Maly
Mark J. Levis
Ellen K. Ritchie
Mark R. Litzow
James K. McCloskey
Catherine C. Smith
Gary J. Schiller
Terrence Bradley
Ramon V. Tiu
Kiran Naqvi
Monique Dail
Satya Siddani
Jing Wang
Brenda Chyla
Paul Lee
Jessica K. Altman
Show All
Source
Cite
Save
Citations (0)
AML-162: Efficacy and Safety of Venetoclax in Combination with Gilteritinib for Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: Updated Analyses of a Phase 1b Study
2021
Clinical Lymphoma, Myeloma & Leukemia
Jessica K. Altman
Naval Daver
Joseph Maly
Mark J. Levis
Ellen K. Ritchie
Mark R. Litzow
James K. McCloskey
Catherine C. Smith
Gary J. Schiller
Terrence J. Bradley
Ramon V. Tiu
Kiran Naqvi
Satya Siddani
Jing Wang
Paul Lee
Alexander E. Perl
Show All
Source
Cite
Save
Citations (2)
1